Total Payments
$8,378
2024 Payments
$2,121
Companies
26
Transactions
161
Medicare Patients
1,541
Medicare Billing
$248,788
Payment Breakdown by Category
Food & Beverage$8,352 (99.7%)
Education$26.46 (0.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,352 | 159 | 99.7% |
| Education | $26.46 | 2 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $2,815 | 50 | $0 (2024) |
| Gilead Sciences, Inc. | $1,326 | 22 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,250 | 30 | $0 (2024) |
| AbbVie Inc. | $604.79 | 22 | $0 (2021) |
| PFIZER INC. | $261.61 | 3 | $0 (2019) |
| Abbott Laboratories | $251.39 | 2 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $235.58 | 3 | $0 (2019) |
| Bayer Healthcare Pharmaceuticals Inc. | $226.28 | 2 | $0 (2024) |
| Horizon Therapeutics plc | $125.54 | 2 | $0 (2022) |
| Circassia Pharmaceuticals Inc | $125.01 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,121 | 27 | AstraZeneca Pharmaceuticals LP ($845.03) |
| 2023 | $1,135 | 26 | AstraZeneca Pharmaceuticals LP ($549.28) |
| 2022 | $662.00 | 14 | AstraZeneca Pharmaceuticals LP ($264.85) |
| 2021 | $774.42 | 17 | AstraZeneca Pharmaceuticals LP ($636.33) |
| 2020 | $329.92 | 9 | Gilead Sciences, Inc. ($120.00) |
| 2019 | $1,108 | 17 | GlaxoSmithKline, LLC. ($330.79) |
| 2018 | $1,030 | 27 | Gilead Sciences, Inc. ($280.32) |
| 2017 | $1,218 | 24 | AbbVie, Inc. ($248.23) |
All Payment Transactions
161 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $22.41 | General |
| Category: Oncology | ||||||
| 12/12/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $97.67 | General |
| Category: RESPIRATORY | ||||||
| 12/12/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $21.88 | General |
| Category: RESPIRATORY | ||||||
| 11/21/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $138.37 | General |
| Category: Diabetes Care | ||||||
| 10/22/2024 | Gilead Sciences, Inc. | Livdelzi (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: INFLAM | ||||||
| 10/17/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $123.54 | General |
| Category: Respiratory | ||||||
| 10/14/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $121.28 | General |
| Category: RESPIRATORY | ||||||
| 10/09/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $118.65 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/30/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/26/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $16.66 | General |
| Category: RESPIRATORY | ||||||
| 09/24/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $121.84 | General |
| 09/05/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $19.29 | General |
| Category: Respiratory | ||||||
| 08/01/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $25.67 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/01/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $3.53 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/27/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $20.36 | General |
| Category: RESPIRATORY | ||||||
| 06/18/2024 | Noven Pharmaceuticals, Inc. | Xelstrym (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: ADHD | ||||||
| 05/30/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $21.96 | General |
| Category: Respiratory | ||||||
| 05/28/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $121.84 | General |
| Category: Respiratory | ||||||
| 05/02/2024 | Gilead Sciences, Inc. | Vemlidy (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: HBV | ||||||
| 04/12/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $103.72 | General |
| Category: Cardio-renal | ||||||
| 03/26/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | Cash or cash equivalent | $93.85 | General |
| Category: Diabetes | ||||||
| 03/14/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $116.64 | General |
| Category: Respiratory | ||||||
| 02/13/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $127.82 | General |
| Category: Respiratory | ||||||
| 02/12/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $123.61 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/26/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $23.58 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 345 | 841 | $141,078 | $64,161 |
| 2022 | 10 | 345 | 844 | $128,094 | $59,766 |
| 2021 | 12 | 444 | 1,041 | $143,720 | $66,388 |
| 2020 | 10 | 407 | 873 | $140,194 | $58,473 |
Total Patients
1,541
Total Services
3,599
Medicare Billing
$248,788
Procedure Codes
43
All Medicare Procedures & Services
43 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 65 | 452 | $99,440 | $48,289 | 48.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 39 | 39 | $8,580 | $5,210 | 60.7% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 53 | 114 | $12,540 | $3,926 | 31.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 15 | 18 | $6,250 | $2,791 | 44.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 47 | 82 | $6,888 | $1,048 | 15.2% |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 2023 | 31 | 31 | $1,550 | $864.90 | 55.8% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 11 | 12 | $1,200 | $599.04 | 49.9% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 28 | 28 | $1,400 | $577.92 | 41.3% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 25 | 25 | $1,250 | $516.00 | 41.3% |
| 94664 | Evaluation of use of breathing device | Office | 2023 | 11 | 14 | $680.00 | $223.86 | 32.9% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2023 | 20 | 26 | $1,300 | $114.14 | 8.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 59 | 423 | $93,060 | $45,751 | 49.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 36 | 36 | $7,920 | $5,072 | 64.0% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2022 | 39 | 81 | $8,910 | $2,874 | 32.3% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2022 | 16 | 47 | $2,350 | $1,359 | 57.8% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 17 | 22 | $2,200 | $1,226 | 55.7% |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 2022 | 35 | 35 | $1,750 | $1,007 | 57.6% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2022 | 34 | 34 | $1,700 | $726.38 | 42.7% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 34 | 34 | $1,700 | $712.58 | 41.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 36 | 56 | $4,704 | $696.57 | 14.8% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2022 | 39 | 76 | $3,800 | $341.18 | 9.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 63 | 370 | $81,400 | $41,215 | 50.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 23 | 47 | $14,100 | $7,240 | 51.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 44 | 44 | $9,680 | $6,345 | 65.5% |
| 94060 | Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration | Office | 2021 | 43 | 92 | $10,120 | $3,861 | 38.2% |
About Wei Xu
Wei Xu is a Legal Medicine healthcare provider based in Gaithersburg, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/18/2007. The National Provider Identifier (NPI) number assigned to this provider is 1932251931.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Wei Xu has received a total of $8,378 in payments from pharmaceutical and medical device companies, with $2,121 received in 2024. These payments were reported across 161 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($8,352).
As a Medicare-enrolled provider, Xu has provided services to 1,541 Medicare beneficiaries, totaling 3,599 services with total Medicare billing of $248,788. Data is available for 4 years (2020–2023), covering 43 distinct procedure/service records.
Ad
Practice Information
- Specialty Legal Medicine
- Location Gaithersburg, MD
- Active Since 01/18/2007
- Last Updated 07/08/2007
- Taxonomy Code 173000000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1932251931
Products in Payments
- BREZTRI (Drug) $1,293
- FARXIGA (Drug) $870.32
- Vemlidy (Drug) $632.34
- TRELEGY ELLIPTA (Drug) $558.65
- Creon (Drug) $524.92
- Epclusa (Drug) $290.37
- FREESTYLE LIBRE 3 (Device) $251.39
- APTIOM (Drug) $235.58
- Kerendia (Drug) $226.28
- AREXVY (Drug) $218.95
- INCRUSE (Drug) $211.61
- ANORO (Drug) $209.29
- ELIQUIS (Drug) $184.20
- BEVESPI AEROSPHERE (Drug) $169.40
- AIRSUPRA (Drug) $127.82
- PENNSAID (Drug) $125.54
- NIOX VERO DEVICE (Device) $125.01
- Livdelzi (Drug) $125.00
- VOQUEZNA (Drug) $125.00
- Xelstrym (Drug) $124.99
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.